Literature DB >> 20691990

A rabbit model for selective portal vein embolization.

Wilmar de Graaf1, Jacomina W van den Esschert, Krijn P van Lienden, Joris J T H Roelofs, Thomas M van Gulik.   

Abstract

BACKGROUND: Portal vein embolization (PVE) is a technique to increase future remnant liver volume. A standardized animal model, resembling the clinical PVE procedure, is needed to clarify some of the unresolved issues surrounding PVE. For this purpose we developed a new rabbit model for PVE.
MATERIALS AND METHODS: Twenty female New Zealand white rabbits were allocated to two protocols, each containing two subgroups. Eighty percent of the liver portal venous system was embolized with polyvinyl-alcohol particles and coils (protocol 1: 300-500 μm particles and one coil; protocol 2: 90-180 μm combined 300-500 μm particles and three coils). In all rabbits CT-volumetry, ICG clearance test, blood sampling, and portography were performed prior to PVE and at d 7 and 14. Additional blood sampling and CT volumetry was done on d 3 and 7.
RESULTS: PVE was technically feasible in the rabbit. CT-volumetry demonstrated a strong correlation with actual liver weight and volume measured at sacrifice. The hypertrophy response was highest at d 7 in both protocols, which was consistent with the amount of proliferating hepatocytes. Protocol 2 showed less revascularization of the portal venous system and demonstrated the highest hypertrophy response. Comparable to the clinical situation, only a small, transient increase in transaminases was observed. There were no changes in liver function parameters after PVE. Histopathologic findings in the rabbit livers were comparable to those found in human livers.
CONCLUSIONS: We successfully devised a rabbit model for PVE, which resembles the human clinical situation.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20691990     DOI: 10.1016/j.jss.2010.04.032

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  5 in total

1.  Yttrium-90 Portal Vein Radioembolization in Sprague-Dawley Rats: Dose-Dependent Imaging and Pathological Changes in Normal Liver.

Authors:  Andrew C Gordon; Sarah B White; Vanessa L Gates; Weiguo Li; Daniel Procissi; Zhuoli Zhang; Kathleen R Harris; Dong-Hyun Kim; Samdeep K Mouli; Reed A Omary; Riad Salem; Andrew C Larson; Robert J Lewandowski
Journal:  Cardiovasc Intervent Radiol       Date:  2020-08-16       Impact factor: 2.740

2.  Acute portal hypertension models in dogs: low- and high-flow approaches.

Authors:  Jaydev K Dave; Ji-Bin Liu; Valgerdur G Halldorsdottir; John R Eisenbrey; Daniel A Merton; Priscilla Machado; Hongjia Zhao; Joseph Altemus; Laurence Needleman; Daniel B Brown; Flemming Forsberg
Journal:  Comp Med       Date:  2012-10       Impact factor: 0.982

3.  Accurate quantitation of Ki67-positive proliferating hepatocytes in rabbit liver by a multicolor immunohistochemical (IHC) approach analyzed with automated tissue and cell segmentation software.

Authors:  Chris M van der Loos; Onno J de Boer; Claire Mackaaij; Lisette T Hoekstra; Thomas M van Gulik; Joanne Verheij
Journal:  J Histochem Cytochem       Date:  2012-09-01       Impact factor: 2.479

4.  Evaluation of the rabbit liver by direct portography and contrast-enhanced computed tomography: anatomical variations of the portal system and hepatic volume quantification.

Authors:  María Páramo; Paula García-Barquin; Eva Santa María; José Miguel Madrid; Meylin Caballeros; Alberto Benito; Bruno Sangro; Mercedes Iñarrairaegui; José Ignacio Bilbao
Journal:  Eur Radiol Exp       Date:  2017-06-29

5.  A new animal model of atrophy-hypertrophy complex and liver damage following Yttrium-90 lobar selective internal radiation therapy in rabbits.

Authors:  María Páramo; Eva Santamaría; Miguel A Idoate; Macarena Rodríguez-Fraile; Alberto Benito; Maria Collantes; Gemma Quincoces; Iván Peñuelas; Carmen Berasain; Josepmaria Argemi; Jorge Quiroga; Bruno Sangro; José I Bilbao; Mercedes Iñarrairaegui
Journal:  Sci Rep       Date:  2022-02-02       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.